European Journal of Epidemiology

, Volume 29, Issue 12, pp 871–885 | Cite as

Early origins of chronic obstructive lung diseases across the life course

  • Liesbeth Duijts
  • Irwin K. Reiss
  • Guy Brusselle
  • Johan C. de Jongste


Chronic obstructive lung diseases, like asthma and chronic obstructive pulmonary disease, have high prevalences and are a major public health concern. Chronic obstructive lung diseases have at least part of their origins in early life. Exposure to an adverse environment during critical periods in early life might lead to permanent developmental adaptations which results in impaired lung growth with smaller airways and lower lung volume, altered immunological responses and related inflammation, and subsequently to increased risks of chronic obstructive lung diseases throughout the life course. Various pathways leading from early life factors to respiratory health outcomes in later life have been studied, including fetal and early infant growth patterns, preterm birth, maternal obesity, diet and smoking, children’s diet, allergen exposure and respiratory tract infections, and genetic susceptibility. Data on potential adverse factors in the embryonic and preconception period and respiratory health outcomes are scarce. Also, the underlying mechanisms how specific adverse exposures in the fetal and early postnatal period lead to chronic obstructive lung diseases in later life are not yet fully understood. Current studies suggest that interactions between early environmental exposures and genetic factors such as changes in DNA-methylation and RNA expression patterns may explain the early development of chronic obstructive lung diseases. New well-designed epidemiological studies are needed to identify specific critical periods and to elucidate the mechanisms underlying the development of chronic obstructive lung disease throughout the life course.


Cohort study Child Asthma Chronic Obstructive Pulmonary Disease (COPD) Early origins 


Chronic obstructive lung diseases during the life course are a major public health concern. Prevalences vary from 5 to 10 % for asthma in childhood [1], with even higher figures for asthma related symptoms such as wheezing in younger children [2], to 5–22 % for chronic obstructive pulmonary disease (COPD) among adults older than 50 years [3]. COPD is presently the fourth most common cause of death worldwide [4]. The most prevalent chronic obstructive lung disease among preterm born children is bronchopulmonary dysplasia [5]. Bronchopulmonary dysplasia is defined as supplemental oxygen need for at least 28 days after birth, and occurs in 30 % among children born younger than 30 weeks of gestation. Chronic obstructive lung diseases in children and adults are related to a reduced quality of life and exercise tolerance, and are leading causes of hospitalisation and health care cost [6, 7, 8, 9]. The morbidity of these diseases remains high despite the availability of effective symptomatic treatments [10, 11]. The lack of curative options seems to be partly due to their unknown aetiology of chronic obstructive lung diseases [12, 13]. Furthermore, definitions of bronchopulmonary dysplasia, asthma and COPD as phenotypes of chronic obstructive lung disease are subject of debate [14, 15, 16, 17, 18]. Bronchopulmonary dysplasia, asthma and COPD have common clinical and physiological features, and may share similar pathogenetic mechanisms. For example, wheezing in childhood with or without lung function reversibility measured by spirometry might be due to bronchopulmonary dysplasia or asthma [19, 20]. Also, the development of COPD or declining lung function seems not fully explained by strong contributors as age and smoking only [3, 21, 22] suggesting that other possible risk factors or lung diseases seem to be important. An accumulating body of evidence suggest that these phenotypes originate in the earliest phase of life [23]. Therefore, the challenge is to identify the specific underlying mechanisms for the associations of adverse exposures in early life with different expressions of chronic obstructive lung diseases, but also their shared early life underlying mechanisms and relation.

Early origins of chronic obstructive lung diseases

The developmental plasticity hypothesis suggests that chronic diseases in later life are the result of adverse early life exposures leading to early adaptation mechanisms [24]. This hypothesis is strongly supported by previous studies published in the European Journal of Epidemiology showing that chronic obstructive lung diseases and other common diseases throughout the life course have at least part of their origins in early life, next to common risk factors [2, 9, 11, 18, 22, 23, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87]. Developmental adaptations in fetal life and infancy due to early life adverse exposures might result in impaired lung growth with smaller airways, decreased lung volume, and subsequently to an increased risk of bronchopulmonary dysplasia, asthma or COPD [88, 89, 90, 91, 92]. Reduced diameter of central and small airways might contribute to the development of chronic obstructive lung diseases [93, 94, 95]. Also, persistent inflammation and its related abnormal immunological responses seem to be associated with asthma and COPD [96]. Long-term follow up studies in different populations have shown that impaired respiratory health or lung function in early childhood is associated with asthma and other respiratory diseases in later life [92, 97, 98, 99, 100, 101, 102]. These studies suggest that lung function and susceptibility for various respiratory diseases track from early childhood onwards. Thus, risk factors for bronchopulmonary dysplasia, asthma or low airway function in childhood might partly predispose for respiratory diseases such as COPD in later life (Fig. 1). Examples of known major risk factors in early life for the development of chronic obstructive lung diseases or low airway function include maternal pre-pregnancy obesity, increased gestational weight gain, increased infant weight gain, inadequate maternal diet during pregnancy and infant diet, and fetal or childhood exposure to tobacco smoke, allergens or respiratory tract infections [19, 103, 104, 105, 106, 107].
Fig. 1

Pathways leading from adverse early life exposures and epigenetics to growth adaptations and chronic obstructive lung diseases across the life course. BPD bronchopulmonary dysplasia, COPD chronic obstructive pulmonary disease

Early growth and development

Birth characteristics

Previously, low birth weight was proposed as an important early risk factor for wheezing and asthma in childhood [108, 109, 110, 111], and COPD and lower pulmonary function in later adult life [88, 89, 112, 113, 114, 115]. Recent studies suggested that low birth weight is not the causal factor per se leading to respiratory morbidity [109, 116, 117, 118]. Previous published findings seem not consistent [108, 109, 110, 111, 119, 120], which may be due to differences in study populations and in definitions of outcomes. Furthermore, the observed associations of low birth weight with increased risks of respiratory morbidity may additionally be confounded by preterm birth or catch-up growth in infancy. The lungs of preterm children have not yet been fully developed, which makes them prone for suboptimal further development [121, 122, 123]. A recent meta-analysis of pooled data observed that preterm birth was associated with an increased risk of wheezing disorders [odds ratio (OR) (95 % confidence interval) 1.46 (1.29, 1.65); 17 studies including 874,710 children], and particularly among children born very preterm [<32 weeks gestation; OR 2.81 (2.55, 3.12)] [124]. Most children with a low birth weight show catch-up growth in infancy [125]. Recent studies suggested that catch-up growth is associated with a lower pulmonary function, and increased risks of childhood asthma [118, 126, 127]. A meta-analysis of individual data from 147,252 children up to the age of 10 years participating in 31 European cohort studies assessed the strength, consistency, and independence of the associations of gestational age, birth weight and infant weight gain with the risks of preschool wheezing and school-age asthma [19]. Remarkably, the authors observed that the associations with preschool wheezing and childhood asthma were not only present for preterm birth below 36 weeks of gestation but across the full range of gestational age at birth. The inverse associations of birth weight with preschool wheezing and school-age asthma were explained by gestational age at birth. Higher infant weight gain was independently associated with higher risks of preschool wheezing and school-age asthma. The highest risk of school-age asthma was observed in children born preterm with high infant weight gain, compared to term born children with normal infant weight gain [OR 4.47 (2.58, 7.76)]. Mechanisms underlying the associations of growth characteristics in early life with asthma outcomes in later childhood might include smaller airways and lungs [128]. The highest rates of airway and alveolar development occur in early life, and growth and development of the airways and alveoli might continue until the age of 21 years [129, 130]. Extreme preterm born children with respiratory distress syndrome or bronchopulmonary dysplasia commonly have an impaired lung function in later life [131, 132]. The forced expiratory volume in 1 s (FEV1) was 16–19 % lower in preterm children compared with term born children, and also 7 % lower in those children without bronchopulmonary dysplasia, according to a recent meta-analysis of 59 studies [20]. Even less extreme preterm born children had lower FEV1 relative to forced vital capacity (FEV1/FVC) and forced expiratory flow at 25–75 % of FVC (FEF25–75) in childhood than term born children [133]. Follow-up studies in preterm children showed persistently lower lung volumes and reduced airway calibre in later life [132, 133, 134, 135, 136]. Other potential underlying pathways for the association between preterm birth and low birth weight and asthma are not disentangled yet but might include underdeveloped anatomical or immunological mechanisms [137, 138, 139], increased allergen sensitization, inflammation and bronchial hyperreactivity [140, 141, 142, 143], interaction with environmental factors, such as smoke exposure and chorioamnionitis [144, 145], or genetic factors [146]. Also, the degree of immaturity, therapeutic interventions and co-morbidity might be important. These different underlying mechanisms may lead to various phenotypes of chronic obstructive lung disease with onset at different ages. The associations of high infant weight gain with childhood asthma may be explained by immunological active factors from adipose tissue, such as leptin [147] which is suggested to have an immunomodulatory role [148]. High infant weight gain might also have a direct mechanical effect on lung function [149]. Further studies are needed to identify the early developmental adaptations of the lungs and immune system that may explain the associations of preterm birth and infant weight gain with childhood asthma.

Fetal and infant growth patterns

Low birth weight is not only the starting point of infant growth, but also the result of various fetal growth patterns. Studies with information about fetal growth characteristics in different periods of pregnancy enable identification of critical fetal periods that might be important for the risk of asthma and other respiratory diseases [150, 151], as previously described in detail [23]. In summary, two birth cohort studies, either prospectively [152] or retrospectively [153] designed, observed that a lower fetal head circumference, abdominal circumference or fetal size was associated with (non)atopic preschool wheezing or asthma in children aged 10 years. However, a prospective population-based cohort study among 5,125 children observed that not fetal growth, but infant weight gain acceleration in early infancy was associated with increased risks of asthma symptoms in preschool children, independent of fetal growth [154]. The associations of longitudinally measured growth patterns from the embryonic to early childhood period with various phenotypes of asthma, lung function and lung structure in childhood and later life adjusted for potential confounders remain to be studied in further detail.

Obesity, inadequate diet and intake of micronutrients

Suboptimal fetal nutrition, due to maternal obesity or underweight, insufficient dietary intake, or placental dysfunction might also affect fetal growth and lung development [113, 155, 156, 157, 158].

Maternal obesity

Maternal pre-pregnancy obesity and gestational weight gain are suggested to be associated with respiratory morbidity of their children. A meta-analysis of 14 studies including 108,321 mother–child pairs observed that maternal overweight or obesity during pregnancy, and to a lesser extent gestational weight gain, were associated with ever asthma or wheeze combined [OR 1.31 (1.16, 1.49)], compared with normal maternal weight during pregnancy and normal gestational weight gain [159]. Only two birth cohorts mutually adjusted for pre-pregnancy weight gain and gestational weight gain, and observed independent and even larger effect estimates of these weight factors for wheeze or asthma [103, 104]. Also, these birth cohorts observed that the associations of maternal pre-pregnancy obesity or gestational weight gain with wheezing or asthma could not be explained by many confounders including child’s growth, infectious and atopic mechanisms, or maternal hypertensive disorders. Thus, further analyses on possible residual confounders specifically focussed on the preconception period and underlying mechanisms, and long-term consequences are needed, as well as prospective randomized trials of maternal weight management before and during pregnancy.

Diet during pregnancy

Insufficient maternal dietary intake of macronutrients during pregnancy may lead to an increased risk of asthma in childhood [155, 160, 161, 162, 163, 164, 165, 166, 167] either directly or through impaired fetal body, lung and airway growth [168, 169]. A systematic review of prospective cohort studies observed that maternal diets rich in fruits and vegetables, fish [170], and foods containing vitamin D, and Mediterranean dietary patterns seem associated with lower risk for asthma or asthma related diseases such as allergy or eczema in their children [107]. Additionally, it has been hypothesized that a shifted balance in maternal consumption of fatty acids during pregnancy with a higher intake of n-6 poly unsaturated fatty acids (n-6 PUFAs) and a lower intake of n-3 PUFAs might have implications for the immature and developing fetal immune system and subsequent risk of asthma and related diseases [171]. Specifically, n-6 PUFAs are suggested to promote sensitization to allergens and to increase allergic disease activity, whereas n-3 PUFAs seem to have an anti-inflammatory effect [171, 172, 173, 174]. So far, previous prospective studies reported inconsistent results on the associations of maternal fatty acid profiles with the risks of childhood asthma and related diseases [175, 176, 177, 178, 179, 180, 181, 182], which seem mainly due to methodological issues. Further studies are needed to explore critical periods of exposure, pathways and causality. The mechanisms by which dietary patterns affect body and lung growth development may include DNA methylation [183, 184]. Lower intake of micronutrients such as folate, and vitamin B12 in mother’s diet may induce epigenetic changes, since folate and vitamin B12 are important methyl donors during pregnancy [185]. Vitamin E has the potential to influence airway development via epigenetic mechanisms because it influences gene expression and airway epithelial cell signalling [163]. The role of epigenetic mechanisms regarding the association of low maternal vitamin D intake during pregnancy with a higher incidence of asthma and wheeze in children is not known yet [186, 187, 188, 189, 190]. Epidemiological studies are currently established worldwide to examine associations of maternal micronutrients intake with DNA methylation levels of their children and subsequent risk of child asthma and related diseases. The importance of the maternal intake of these micronutrients on respiratory health in childhood and adulthood might differ between developing and Western countries, since the nutritional status of mothers and children in these countries are different.

Placental dysfunction

Not only maternal diet, but also placental dysfunction might contribute to respiratory disease in children. Placental dysfunction is strongly related to fetal growth and childhood cardiovascular adaptations [191], but its direct associations with respiratory health in the offspring are not fully understood yet.

Infant diet

After birth, specific infant feeding patterns may lead to reduced lung and airway growth and increased risk of childhood asthma [192, 193, 194, 195, 196]. A recent meta-analysis of 75 studies observed that breastfeeding was associated with a reduced risk of ever asthma, recent asthma, and recent wheezing illness [pooled ORs 0.78 (0.74, 0.84), 0.76 (0.67, 0.86), and 0.81 (0.76, 0.87), respectively] [197]. Longer duration and exclusiveness of breastfeeding tended to be associated with a stronger reduced risk of asthma. Furthermore, it was observed that the protective effect of breastfeeding for respiratory morbidity was the strongest at age 0–2 years, diminished thereafter but was still present at school age. Underlying mechanisms that have been suggested to explain the associations of shorter duration or smaller amount of breastfeeding with the risks of asthma are breast milk components that stimulate the infant’s innate immune system and growth [198, 199, 200] but might be mediated by genetic susceptibility, atopic and infectious mechanisms [194, 195, 201, 202]. Further studies are needed to explore in detail the role of atopy, infections, suboptimal lung growth [203], epigenetic changes [204], other dietary macro- and micronutrient components or other possible underlying mechanisms for the associations between breastfeeding and asthma.

Exposure to tobacco smoke, allergens and respiratory infections

Maternal tobacco smoking

The most important adverse exposure for chronic obstructive lung diseases in childhood is maternal tobacco smoking [106, 205, 206, 207, 208, 209, 210, 211, 212]. Identifying critical periods of exposure to maternal smoking is necessary. Recently, it was observed that not first trimester smoking but continued maternal smoking throughout pregnancy was associated with an increased risk of preschool wheezing independent of paternal smoking, smoke exposure in childhood and being small for gestational age suggesting a direct adverse effect of fetal tobacco smoke exposure on lung development [213]. In contrast with this study, a recent meta-analysis among 21,600 children of European birth cohorts observed that specifically maternal smoking during first trimester of pregnancy was associated with a 1.45 and 2.10 fold increased risk of preschool wheezing and childhood asthma, respectively, with a dose–response effect [106]. The number of subjects included or the use of different confounders might explain differences in findings. The results suggest that the embryonic and maybe the preconception period might be vulnerable periods for adaptations of the lungs and immune system and subsequently development of chronic obstructive lung disease in later life. In the last few years, electronic cigarettes have been suggested to generate less tar and carcinogens than regular cigarettes [214]. However, the use, dosage and frequency of electronic cigarettes by mothers during pregnancy and the risk of chronic obstructive lung diseases of their children have not been studied. Thus, use of electronic cigarettes should be discouraged. The mechanisms by which maternal smoking during pregnancy affect child’s chronic obstructive lung disease are not fully understood, but may include suboptimal development of the respiratory tract system, which results in reduced airway calibers and lower lung function [215, 216, 217, 218]. Previous studies suggest that children with asthma already have a reduced lung function in the first months of life, and that this deficit tracks or progresses into childhood and early adulthood [219, 220]. This process might be accelerated by any additional adverse exposures in a period of the highest airway and alveolar development rates [221]. This is supported by a pooled data analysis of 20,000 children, which reported that independent of current passive smoke exposure, maternal smoking during pregnancy seems associated with lower lung function in childhood [222]. According to a recent randomized clinical trial, the adverse effect of maternal smoking during pregnancy on respiratory morbidity of the child might be weakened by vitamin C use during pregnancy, but its beneficial effects on lung function is less clear [223]. Alternatively to suboptimal development of the respiratory tract system, recent studies propose that maternal smoking during pregnancy changes the expression of asthma susceptibility genes by a reduction of histone deacetylase activity and changes in DNA-methylation patterns [224, 225, 226]. Specific genetic variants related to asthma, many of them located in chromosomal region 17q12–q21, seem modified by tobacco smoke exposure during pregnancy and other environmental factors [225, 226, 227, 228]. Thus far it is not known to what extent these epigenetic changes persist throughout life or which specific critical periods for epigenetic changes are important to have a long lasting effect on the risk of impaired lung function and chronic obstructive lung diseases in later life.

Allergen exposure

Exposure to allergens in early life and the development of IgE-mediated sensitisation and eventually allergic diseases are not fully understood. It has been proposed that an increased exposure to allergens, for example dust mite, leads to an increased risk of specific sensitization and asthma [229, 230]. However, results of studies are inconsistent. Furthermore, children vary widely in the clinical expression of atopic diseases, ranging from mild symptoms of rhinitis, asthma, or eczema to severe life-threatening anaphylactic shock. This implies a more complex association of allergen exposure with the development of IgE-sensitisation patterns and allergic diseases. Recent research suggests that atopic diseases may be accurately reflected by atopic phenotypes consisting of distinct IgE-mediated sensitization patterns for foods and inhalant allergens. Four recent birth cohort studies of 500–1,000 children aged 2–18 years have identified such phenotypes [105, 231, 232, 233]. Although the specific categorization of the atopic phenotypes differed across cohorts, they observed that a multiple or mixed food and inhalant sensitization atopic phenotype was most strongly associated with asthma [ORs 11.9 (7.3, 19.4) to 29.3 (11.1, 77.2)], compared with the never sensitization phenotype, while inconsistent results were observed for lung function outcomes, allergic rhinitis, and eczema. Identification of these atopic phenotypes will enable better identification of specific dietary and environmental exposures, and (epi)genetic mechanisms that might be involved in the development of asthma and other atopic diseases. Also, associations of allergen exposure in early fetal and childhood life, and its possible cumulative and dose-response effect, with chronic obstructive lung and related diseases need to be explored. Data are currently lacking [234].

Respiratory tract infections

Childhood asthma symptoms or wheezing are predominantly related to respiratory tract infections in the preschool age [235, 236, 237, 238, 239]. Respiratory infectious diseases in infancy might also predict the risk of asthma and other respiratory diseases in childhood and adulthood [91, 240, 241, 242]. Viral respiratory infections, of which respiratory syncytial virus and human rhinovirus have been studied the most, are related with an increased risk of asthma [237, 243, 244]. A meta-analysis observed that a history of respiratory syncytial virus was associated with a 3.8 fold increased risk of asthma in childhood [245] but that this risk declined for asthma at older ages. Mechanisms that lead from viral infections to asthma comprise various immunological pathways but viral infections and asthma might also be the result of the same impaired developed immune system, low lung function or genetic susceptibility [246]. Signs of evidence for a causal relationship have recently been observed. A randomized control trial among 429 healthy preterm infants reported a 61 % reduction of wheezing in the first year of life when children were given respiratory syncytial virus prophylaxis compared with those children who received a placebo [247]. Human rhinovirus infections in early life have been associated with a 2.9 fold-increased risk of asthma [244, 248] and even stronger if children are IgE-sensitised. Their underlying mechanisms need to be further explored but genetic susceptibility might be involved [249]. Not only viral, but also bacterial respiratory infections are associated with asthma symptoms [237]. Wheezing episodes seem associated with overall presence of H. influenzae, M. catarrhalis, or S. pneumoniae [OR 2.9 (1.9, 4.3)], independent of virus infections, or previous colonization of the airways with these bacterial pathogens [238]. Whether these associations reflect causal mechanisms or a common underlying factor, such as susceptible lung, is not known. Also, the effect of maternal infections during pregnancy on childhood asthma needs to be fully explored. Maternal antibiotic use during pregnancy has been associated with increased risk of hospital admission for childhood asthma, outpatient attendance and corticosteroid use [adjusted incidence rate ratio (95 % CI) 1.24 (1.18, 1.30), 1.22 (1.18, 1.26), and 1.18 (1.15, 1.20), respectively] providing indirect observational evidence. Moreover, maternal antibiotic use not only during pregnancy, but also 80 weeks before pregnancy was associated in a dose dependent manner with hospital admission, outpatient attendance and corticosteroid use of their children [250]. This implies that not only the fetal period, but also the preconceptional period seems important for the development of childhood asthma.

Genetic susceptibility and epigenetics

Previous candidate gene studies and linkage studies identified more than 100 genes associated with asthma [251, 252]. However, most of these associations could not be replicated. More recent genome wide approaches (GWAS) in large study populations successfully identified and replicated genetic variants related to asthma in children [253, 254, 255, 256, 257, 258, 259, 260, 261, 262] or COPD [263] and related lung function in adults [264, 265, 266, 267]. Most consistent reported asthma-related loci were observed at or near ORMDL3GSDMB genes on chromosome 17, but for childhood asthma only [268]. Other examples of reported asthma-related loci are CHI3L1, IL6R, and DENND1B on chromosome 1, IL1RL1IL18R1 on chromosome 2, PDE4D and RAD50IL13 on chromosome 5, HLA-DQ on chromosome 6, IL33 on chromosome 9, SMAD3 on chromosome 15, and IL2RB on chromosome 22 [253, 254, 255, 256, 257, 258, 259, 260, 261]. For COPD, GWAS studies reported related loci at or near genes for HHIP and FAM13a on chromosome 4, CDH6 at chromosome 5, CSMD1 at chromosome 8, PARD3, ADARB2 and TMEM72-ASI at chromosome 10, RIN3 at chromosome 14, and 15q25 and 19q13 loci [263]. Associations of genetic variants with lung function have been reported for 7 genes located on chromosome 11 including MIR129-2, PRDM11, PTCH1, TMEM26, ANK3, FOXA1 and HSD17B12 and also for EFEMP1 on chromosome 2, BMP6 on chromosome 6, WWOX on chromosome 12, the IL16/STARD5/TMC3 locus on chromosome 15 and KCNJ2 on chromosome 21 [264, 265, 266, 267]. Taken together, GWAS studies have provided important new information on the mechanisms involved in pathogenesis of chronic obstructive lung diseases and lung function. However, observed effects are weak and account for only a small proportion of the heritability of the disease, and so far seem to have little prognostic utility.

The effects of early life exposures such as maternal smoking and diet, breastfeeding and infant infectious diseases on the risk of asthma and COPD might be modified by a genetic susceptibility [167, 224, 227, 269, 270, 271, 272], but results are not consistent. An accumulating body of evidence suggests that the underlying molecular mechanisms leading from adverse exposures in early life to respiratory adaptations and diseases in later life include epigenetic modifications. Epigenetic modifications are changes in the genetic material that do not affect the DNA sequence and include DNA methylation, histone modifications and non-coding RNAs [273]. DNA methylation is the most well understood mechanism in epidemiological population-based studies. Changes in DNA methylation of CpG dinucleotides of specific gene regions frequently occur in early life. These changes are influenced by several environmental exposures and might affect gene expression. Recent studies showed general and biological pathway-specific differences in DNA methylation in children from mothers who smoked during pregnancy and in mothers and children with specific dietary patterns [183, 184, 226, 274, 275, 276, 277, 278]. Studies focusing on the role of epigenetics on the development of respiratory outcomes showed that DNA methylation status related to specific genes is associated with both the presence and severity of COPD [279], decreased lung function [280], asthma [281], and other atopic diseases [226, 274, 282, 283, 284, 285]. However, these studies assessed candidate gene-specific epigenetic modifications, and were not able to relate selected loci with gene expression, and subsequently to lung structure, lung function and respiratory disease. Thus, future studies are needed to relate adverse fetal exposures with DNA methylation, repeatedly measured in early life, and with RNA and protein expression and subsequent structural, functional and clinical respiratory outcomes in childhood, adolescence and adulthood.


Chronic obstructive lung diseases from birth until adulthood are heterogeneous, and the underlying origins remain partly unknown. Several lines of research suggest that chronic obstructive lung diseases such as asthma and COPD have at least part of their origins in fetal life and early childhood. Further exploration of critical periods are needed and therefore focus for further research should be on the embryonic and preconception period to identify specific embryonic, fetal and infant growth patterns, their specific adverse exposures and gene-environment interactions leading to chronic obstructive lung disease across the life course. Specific early exposures of interest include maternal obesity, diet and dietary patterns, intake of macro- and specific micronutrients and supplements, smoking, and child’s diet, allergen exposure, and respiratory infectious diseases in early life. Developmental adaptation mechanisms in early life that need to be studied in epidemiological study design include DNA methylation, RNA expression, and detailed imaging and functional assessments of the airways and lungs. Newly identified contributing factors to the origins of chronic obstructive lung diseases might ultimately contribute to the development of novel strategies for the early identification of high-risk groups, and for targeted primary prevention in population-based settings.



Liesbeth Duijts received funding from the Lung Foundation Netherlands (no; 2012).

Conflict of interest

The authors have no conflict of interest.


  1. 1.
    Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733–43. doi:10.1016/S0140-6736(06)69283-0.PubMedGoogle Scholar
  2. 2.
    Broms K, Norback D, Sundelin C, Eriksson M, Svardsudd K. A nationwide study of asthma incidence rate and its determinants in Swedish pre-school children. Eur J Epidemiol. 2012;27(9):695–703. doi:10.1007/s10654-012-9725-3.PubMedGoogle Scholar
  3. 3.
    Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–50. doi:10.1016/S0140-6736(07)61377-4.PubMedGoogle Scholar
  4. 4.
    World Health Organization S. World Health Statistics. 2008.Google Scholar
  5. 5.
    Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443–56. doi:10.1542/peds.2009-2959.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Welsh L, Kirkby J, Lum S, et al. The EPICure study: maximal exercise and physical activity in school children born extremely preterm. Thorax. 2010;65(2):165–72. doi:10.1136/thx.2008.107474.PubMedGoogle Scholar
  7. 7.
    Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–78. doi:10.1111/j.1398-9995.2004.00526.x.PubMedGoogle Scholar
  8. 8.
    Frisk B, Espehaug B, Hardie JA, et al. Physical activity and longitudinal change in 6-min walk distance in COPD patients. Respir Med. 2014;108(1):86–94. doi:10.1016/j.rmed.2013.09.004.PubMedGoogle Scholar
  9. 9.
    Heikkinen SA, Quansah R, Jaakkola JJ, Jaakkola MS. Effects of regular exercise on adult asthma. Eur J Epidemiol. 2012;27(6):397–407. doi:10.1007/s10654-012-9684-8.PubMedGoogle Scholar
  10. 10.
    Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world evaluation of asthma control and treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol. 2007;119(6):1454–61. doi:10.1016/j.jaci.2007.03.022.PubMedGoogle Scholar
  11. 11.
    Figarska SM, Boezen HM, Vonk JM. Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study. Eur J Epidemiol. 2012;27(11):867–76. doi:10.1007/s10654-012-9736-0.PubMedCentralPubMedGoogle Scholar
  12. 12.
    Behrens T. Current trends in aetiological asthma research. Eur J Epidemiol. 2009;24(3):115–8. doi:10.1007/s10654-009-9318-y.PubMedGoogle Scholar
  13. 13.
    Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718. doi:10.1164/rccm.200811-1757ST.PubMedGoogle Scholar
  14. 14.
    Bancalari EH, Jobe AH. The respiratory course of extremely preterm infants: a dilemma for diagnosis and terminology. J Pediatr. 2012;161(4):585–8. doi:10.1016/j.jpeds.2012.05.054.PubMedGoogle Scholar
  15. 15.
    Ducharme FM, Tse SM, Chauhan B. Diagnosis, management, and prognosis of preschool wheeze. Lancet. 2014;383(9928):1593–604. doi:10.1016/S0140-6736(14)60615-2.PubMedGoogle Scholar
  16. 16.
    Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99. doi:10.1164/rccm.200801-060ST.PubMedGoogle Scholar
  17. 17.
    Agusti A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med. 2011;183(9):1129–37. doi:10.1164/rccm.201009-1414PP.PubMedGoogle Scholar
  18. 18.
    Pekkanen J, Lampi J, Genuneit J, Hartikainen AL, Jarvelin MR. Analyzing atopic and non-atopic asthma. Eur J Epidemiol. 2012;27(4):281–6. doi:10.1007/s10654-012-9649-y.PubMedGoogle Scholar
  19. 19.
    Sonnenschein-van der Voort AM, Arends LR, de Jongste JC, et al. Preterm birth, infant weight gain, and childhood asthma risk: a meta-analysis of 147,000 European children. J Allergy Clin Immunol. 2014;133(5):1317–29. doi:10.1016/j.jaci.2013.12.1082.PubMedCentralPubMedGoogle Scholar
  20. 20.
    Kotecha SJ, Edwards MO, Watkins WJ, et al. Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax. 2013;68(8):760–6. doi:10.1136/thoraxjnl-2012-203079.PubMedGoogle Scholar
  21. 21.
    Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73. doi:10.1016/S0140-6736(07)61380-4.PubMedGoogle Scholar
  22. 22.
    Baughman P, Marott JL, Lange P, et al. Combined effect of lung function level and decline increases morbidity and mortality risks. Eur J Epidemiol. 2012;27(12):933–43. doi:10.1007/s10654-012-9750-2.PubMedGoogle Scholar
  23. 23.
    Duijts L. Fetal and infant origins of asthma. Eur J Epidemiol. 2012;27(1):5–14. doi:10.1007/s10654-012-9657-y.PubMedCentralPubMedGoogle Scholar
  24. 24.
    Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359(1):61–73. doi:10.1056/NEJMra0708473.PubMedCentralPubMedGoogle Scholar
  25. 25.
    Firoozi F, Lemiere C, Beauchesne MF, Perreault S, Forget A, Blais L. Impact of maternal asthma on perinatal outcomes: a two-stage sampling cohort study. Eur J Epidemiol. 2012;27(3):205–14. doi:10.1007/s10654-012-9654-1.PubMedGoogle Scholar
  26. 26.
    Johnson PC, Logue J, McConnachie A, et al. Intergenerational change and familial aggregation of body mass index. Eur J Epidemiol. 2012;27(1):53–61. doi:10.1007/s10654-011-9639-5.PubMedGoogle Scholar
  27. 27.
    Petersen CB, Gronbaek M, Helge JW, Thygesen LC, Schnohr P, Tolstrup JS. Changes in physical activity in leisure time and the risk of myocardial infarction, ischemic heart disease, and all-cause mortality. Eur J Epidemiol. 2012;27(2):91–9. doi:10.1007/s10654-012-9656-z.PubMedGoogle Scholar
  28. 28.
    Iversen LB, Strandberg-Larsen K, Prescott E, Schnohr P, Rod NH. Psychosocial risk factors, weight changes and risk of obesity: the Copenhagen City Heart Study. Eur J Epidemiol. 2012;27(2):119–30. doi:10.1007/s10654-012-9659-9.PubMedGoogle Scholar
  29. 29.
    Patel S, Henderson J, Jeffreys M, Davey Smith G, Galobardes B. Associations between socioeconomic position and asthma: findings from a historical cohort. Eur J Epidemiol. 2012;27(8):623–31. doi:10.1007/s10654-012-9703-9.PubMedCentralPubMedGoogle Scholar
  30. 30.
    Gabriele C, Silva LM, Arends LR, et al. Early respiratory morbidity in a multicultural birth cohort: the Generation R Study. Eur J Epidemiol. 2012;27(6):453–62. doi:10.1007/s10654-012-9675-9.PubMedCentralPubMedGoogle Scholar
  31. 31.
    Brostrom EB, Akre O, Katz-Salamon M, Jaraj D, Kaijser M. Obstructive pulmonary disease in old age among individuals born preterm. Eur J Epidemiol. 2013;28(1):79–85. doi:10.1007/s10654-013-9761-7.PubMedGoogle Scholar
  32. 32.
    Rossi IA, Bochud M, Bovet P, et al. Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations. Eur J Epidemiol. 2012;27(5):379–84. doi:10.1007/s10654-012-9671-0.PubMedGoogle Scholar
  33. 33.
    Nan C, Guo B, Warner C, et al. Heritability of body mass index in pre-adolescence, young adulthood and late adulthood. Eur J Epidemiol. 2012;27(4):247–53. doi:10.1007/s10654-012-9678-6.PubMedGoogle Scholar
  34. 34.
    Baba S, Wikstrom AK, Stephansson O, Cnattingius S. Influence of smoking and snuff cessation on risk of preterm birth. Eur J Epidemiol. 2012;27(4):297–304. doi:10.1007/s10654-012-9676-8.PubMedGoogle Scholar
  35. 35.
    Ma L, Oei L, Jiang L, et al. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol. 2012;27(5):319–32. doi:10.1007/s10654-012-9674-x.PubMedCentralPubMedGoogle Scholar
  36. 36.
    Kharazmi E, Lukanova A, Teucher B, Gross ML, Kaaks R. Does pregnancy or pregnancy loss increase later maternal risk of diabetes? Eur J Epidemiol. 2012;27(5):357–66. doi:10.1007/s10654-012-9683-9.PubMedGoogle Scholar
  37. 37.
    Demakakos P, Marmot M, Steptoe A. Socioeconomic position and the incidence of type 2 diabetes: the ELSA study. Eur J Epidemiol. 2012;27(5):367–78. doi:10.1007/s10654-012-9688-4.PubMedGoogle Scholar
  38. 38.
    Tamayo T, Jacobs DR Jr, Strassburger K, et al. Race- and sex-specific associations of parental education with insulin resistance in middle-aged participants: the CARDIA study. Eur J Epidemiol. 2012;27(5):349–55. doi:10.1007/s10654-012-9691-9.PubMedGoogle Scholar
  39. 39.
    Park SY, Wilkens LR, Murphy SP, Monroe KR, Henderson BE, Kolonel LN. Body mass index and mortality in an ethnically diverse population: the Multiethnic Cohort Study. Eur J Epidemiol. 2012;27(7):489–97. doi:10.1007/s10654-012-9695-5.PubMedGoogle Scholar
  40. 40.
    van Oeffelen AA, Agyemang C, Bots ML, et al. The relation between socioeconomic status and short-term mortality after acute myocardial infarction persists in the elderly: results from a nationwide study. Eur J Epidemiol. 2012;27(8):605–13. doi:10.1007/s10654-012-9700-z.PubMedCentralPubMedGoogle Scholar
  41. 41.
    Nuesch E, Dale CE, Amuzu A, et al. Inflammation, coagulation and risk of locomotor disability in elderly women: findings from the British Women’s Heart and Health Study. Eur J Epidemiol. 2012;27(8):633–45. doi:10.1007/s10654-012-9706-6.PubMedGoogle Scholar
  42. 42.
    Galli L, Salpietro S, Pellicciotta G, et al. Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy. Eur J Epidemiol. 2012;27(8):657–65. doi:10.1007/s10654-012-9707-5.PubMedGoogle Scholar
  43. 43.
    Grau M, Sala C, Sala J, et al. Sex-related differences in prognosis after myocardial infarction: changes from 1978 to 2007. Eur J Epidemiol. 2012;27(11):847–55. doi:10.1007/s10654-012-9712-8.PubMedGoogle Scholar
  44. 44.
    Lagerros YT, Cnattingius S, Granath F, Hanson U, Wikstrom AK. From infancy to pregnancy: birth weight, body mass index, and the risk of gestational diabetes. Eur J Epidemiol. 2012;27(10):799–805. doi:10.1007/s10654-012-9721-7.PubMedGoogle Scholar
  45. 45.
    Lissner L, Lanfer A, Gwozdz W, et al. Television habits in relation to overweight, diet and taste preferences in European children: the IDEFICS study. Eur J Epidemiol. 2012;27(9):705–15. doi:10.1007/s10654-012-9718-2.PubMedCentralPubMedGoogle Scholar
  46. 46.
    Chowdhury R, Stevens S, Ward H, Chowdhury S, Sajjad A, Franco OH. Circulating vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta-analysis. Eur J Epidemiol. 2012;27(8):581–91. doi:10.1007/s10654-012-9729-z.PubMedGoogle Scholar
  47. 47.
    Nordahl H, Rod NH, Frederiksen BL, et al. Education and risk of coronary heart disease: assessment of mediation by behavioral risk factors using the additive hazards model. Eur J Epidemiol. 2013;28(2):149–57. doi:10.1007/s10654-012-9745-z.PubMedGoogle Scholar
  48. 48.
    Larsson SC, Orsini N, Wolk A. Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis. Eur J Epidemiol. 2012;27(12):895–901. doi:10.1007/s10654-012-9748-9.PubMedGoogle Scholar
  49. 49.
    Jacobsen BK, Knutsen SF, Oda K, Fraser GE. Obesity at age 20 and the risk of miscarriages, irregular periods and reported problems of becoming pregnant: the Adventist Health Study-2. Eur J Epidemiol. 2012;27(12):923–31. doi:10.1007/s10654-012-9749-8.PubMedCentralPubMedGoogle Scholar
  50. 50.
    Karppi J, Kurl S, Makikallio TH, Ronkainen K, Laukkanen JA. Low levels of plasma carotenoids are associated with an increased risk of atrial fibrillation. Eur J Epidemiol. 2013;28(1):45–53. doi:10.1007/s10654-012-9753-z.PubMedGoogle Scholar
  51. 51.
    Kiefte-de Jong JC, Chowdhury R, Franco OH. Fish intake or omega-3 fatty acids: greater than the sum of all parts? Eur J Epidemiol. 2012;27(12):891–4. doi:10.1007/s10654-012-9757-8.PubMedGoogle Scholar
  52. 52.
    Clays E, De Bacquer D, Janssens H, et al. The association between leisure time physical activity and coronary heart disease among men with different physical work demands: a prospective cohort study. Eur J Epidemiol. 2013;28(3):241–7. doi:10.1007/s10654-013-9764-4.PubMedGoogle Scholar
  53. 53.
    Pequignot R, Tzourio C, Peres K, et al. Depressive symptoms, antidepressants and disability and future coronary heart disease and stroke events in older adults: the Three City Study. Eur J Epidemiol. 2013;28(3):249–56. doi:10.1007/s10654-013-9765-3.PubMedGoogle Scholar
  54. 54.
    Miettola S, Hartikainen AL, Vaarasmaki M, et al. Offspring’s blood pressure and metabolic phenotype after exposure to gestational hypertension in utero. Eur J Epidemiol. 2013;28(1):87–98. doi:10.1007/s10654-013-9763-5.PubMedGoogle Scholar
  55. 55.
    Behrens G, Matthews CE, Moore SC, et al. The association between frequency of vigorous physical activity and hepatobiliary cancers in the NIH-AARP Diet and Health Study. Eur J Epidemiol. 2013;28(1):55–66. doi:10.1007/s10654-013-9767-1.PubMedCentralPubMedGoogle Scholar
  56. 56.
    Schottker B, Herder C, Rothenbacher D, Perna L, Muller H, Brenner H. Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults. Eur J Epidemiol. 2013;28(3):267–75. doi:10.1007/s10654-013-9769-z.PubMedGoogle Scholar
  57. 57.
    Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28(1):1–19. doi:10.1007/s10654-013-9762-6.PubMedGoogle Scholar
  58. 58.
    Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169–80. doi:10.1007/s10654-013-9771-5.PubMedCentralPubMedGoogle Scholar
  59. 59.
    Tennant PW, Parker L, Thomas JE, Craft SA, Pearce MS. Childhood infectious disease and premature death from cancer: a prospective cohort study. Eur J Epidemiol. 2013;28(3):257–65. doi:10.1007/s10654-013-9775-1.PubMedGoogle Scholar
  60. 60.
    Sabanayagam C, Wong TY, Xiao J, Shankar A. Serum cystatin C and prediabetes in non-obese US adults. Eur J Epidemiol. 2013;28(4):311–6. doi:10.1007/s10654-013-9781-3.PubMedGoogle Scholar
  61. 61.
    Mishra GD, Chiesa F, Goodman A, De Stavola B, Koupil I. Socio-economic position over the life course and all-cause, and circulatory diseases mortality at age 50–87 years: results from a Swedish birth cohort. Eur J Epidemiol. 2013;28(2):139–47. doi:10.1007/s10654-013-9777-z.PubMedGoogle Scholar
  62. 62.
    Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol. 2013;28(3):205–21. doi:10.1007/s10654-013-9790-2.PubMedGoogle Scholar
  63. 63.
    Virta JJ, Heikkila K, Perola M, et al. Midlife cardiovascular risk factors and late cognitive impairment. Eur J Epidemiol. 2013;28(5):405–16. doi:10.1007/s10654-013-9794-y.PubMedGoogle Scholar
  64. 64.
    Behrens G, Fischer B, Kohler S, Park Y, Hollenbeck AR, Leitzmann MF. Healthy lifestyle behaviors and decreased risk of mortality in a large prospective study of US women and men. Eur J Epidemiol. 2013;28(5):361–72. doi:10.1007/s10654-013-9796-9.PubMedGoogle Scholar
  65. 65.
    Threapleton DE, Greenwood DC, Burley VJ, Aldwairji M, Cade JE. Dietary fibre and cardiovascular disease mortality in the UK Women’s Cohort Study. Eur J Epidemiol. 2013;28(4):335–46. doi:10.1007/s10654-013-9799-6.PubMedGoogle Scholar
  66. 66.
    Westerlund A, Bellocco R, Sundstrom J, Adami HO, Akerstedt T, Trolle Lagerros Y. Sleep characteristics and cardiovascular events in a large Swedish cohort. Eur J Epidemiol. 2013;28(6):463–73. doi:10.1007/s10654-013-9802-2.PubMedGoogle Scholar
  67. 67.
    Naver KV, Secher NJ, Ovesen PG, Gorst-Rasmussen A, Lundbye-Christensen S, Nilas L. Offspring preterm birth and birth size are related to long-term risk of maternal diabetes. Eur J Epidemiol. 2013;28(5):427–32. doi:10.1007/s10654-013-9805-z.PubMedGoogle Scholar
  68. 68.
    Anic GM, Madden MH, Sincich K, et al. Early life exposures and the risk of adult glioma. Eur J Epidemiol. 2013;28(9):753–8. doi:10.1007/s10654-013-9811-1.PubMedCentralPubMedGoogle Scholar
  69. 69.
    Ludvigsson JF, Zugna D, Cnattingius S, et al. Influenza H1N1 vaccination and adverse pregnancy outcome. Eur J Epidemiol. 2013;28(7):579–88. doi:10.1007/s10654-013-9813-z.PubMedGoogle Scholar
  70. 70.
    Wu Y, Li S, Zhang D. Circulating 25-hydroxyvitamin D levels and hypertension risk. Eur J Epidemiol. 2013;28(7):611–6. doi:10.1007/s10654-013-9817-8.PubMedGoogle Scholar
  71. 71.
    Ahmadi-Abhari S, Luben RN, Wareham NJ, Khaw KT. Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study. Eur J Epidemiol. 2013;28(7):541–50. doi:10.1007/s10654-013-9819-6.PubMedGoogle Scholar
  72. 72.
    Rahman I, Humphreys K, Bennet AM, Ingelsson E, Pedersen NL, Magnusson PK. Clinical depression, antidepressant use and risk of future cardiovascular disease. Eur J Epidemiol. 2013;28(7):589–95. doi:10.1007/s10654-013-9821-z.PubMedGoogle Scholar
  73. 73.
    Jorde R, Schirmer H, Njolstad I, et al. Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromso Study. Eur J Epidemiol. 2013;28(7):569–78. doi:10.1007/s10654-013-9822-y.PubMedGoogle Scholar
  74. 74.
    Faeh D, Rohrmann S, Braun J. Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts. Eur J Epidemiol. 2013;28(7):551–5. doi:10.1007/s10654-013-9827-6.PubMedGoogle Scholar
  75. 75.
    Dai X, Yuan J, Yao P, et al. Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population. Eur J Epidemiol. 2013;28(8):669–76. doi:10.1007/s10654-013-9829-4.PubMedGoogle Scholar
  76. 76.
    Novak M, Toren K, Lappas G, et al. Occupational status and incidences of ischemic and hemorrhagic stroke in Swedish men: a population-based 35-year prospective follow-up study. Eur J Epidemiol. 2013;28(8):697–704. doi:10.1007/s10654-013-9833-8.PubMedGoogle Scholar
  77. 77.
    Kelly-Irving M, Lepage B, Dedieu D, et al. Adverse childhood experiences and premature all-cause mortality. Eur J Epidemiol. 2013;28(9):721–34. doi:10.1007/s10654-013-9832-9.PubMedCentralPubMedGoogle Scholar
  78. 78.
    Min JY, Min KB. Serum C-peptide levels as an independent predictor of diabetes mellitus mortality in non-diabetic individuals. Eur J Epidemiol. 2013;28(9):771–4. doi:10.1007/s10654-013-9836-5.PubMedGoogle Scholar
  79. 79.
    Malerba S, Turati F, Galeone C, et al. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol. 2013;28(7):527–39. doi:10.1007/s10654-013-9834-7.PubMedGoogle Scholar
  80. 80.
    Julin B, Wolk A, Thomas LD, Akesson A. Exposure to cadmium from food and risk of cardiovascular disease in men: a population-based prospective cohort study. Eur J Epidemiol. 2013;28(10):837–40. doi:10.1007/s10654-013-9841-8.PubMedGoogle Scholar
  81. 81.
    Mons U, Schottker B, Muller H, Kliegel M, Brenner H. History of lifetime smoking, smoking cessation and cognitive function in the elderly population. Eur J Epidemiol. 2013;28(10):823–31. doi:10.1007/s10654-013-9840-9.PubMedGoogle Scholar
  82. 82.
    Buijsse B, Boeing H, Hirche F, et al. Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident type 2 diabetes: a prospective case-cohort study. Eur J Epidemiol. 2013;28(9):743–52. doi:10.1007/s10654-013-9844-5.PubMedGoogle Scholar
  83. 83.
    Hou L, Lloyd-Jones DM, Ning H, et al. White blood cell count in young adulthood and coronary artery calcification in early middle age: coronary artery risk development in young adults (CARDIA) study. Eur J Epidemiol. 2013;28(9):735–42. doi:10.1007/s10654-013-9842-7.PubMedGoogle Scholar
  84. 84.
    Rozendaal AM, van Essen AJ, te Meerman GJ, et al. Periconceptional folic acid associated with an increased risk of oral clefts relative to non-folate related malformations in the Northern Netherlands: a population based case-control study. Eur J Epidemiol. 2013;28(11):875–87. doi:10.1007/s10654-013-9849-0.PubMedGoogle Scholar
  85. 85.
    Luque-Fernandez MA, Franco M, Gelaye B, et al. Unemployment and stillbirth risk among foreign-born and Spanish pregnant women in Spain, 2007–2010: a multilevel analysis study. Eur J Epidemiol. 2013;28(12):991–9. doi:10.1007/s10654-013-9859-y.PubMedGoogle Scholar
  86. 86.
    Schmidt M, Botker HE, Pedersen L, Sorensen HT. Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study. Eur J Epidemiol. 2014;29(2):111–8. doi:10.1007/s10654-013-9867-y.PubMedGoogle Scholar
  87. 87.
    Kunutsor SK, Burgess S, Munroe PB, Khan H. Vitamin D and high blood pressure: causal association or epiphenomenon? Eur J Epidemiol. 2014;29(1):1–14. doi:10.1007/s10654-013-9874-z.PubMedGoogle Scholar
  88. 88.
    Canoy D, Pekkanen J, Elliott P, et al. Early growth and adult respiratory function in men and women followed from the fetal period to adulthood. Thorax. 2007;62(5):396–402.PubMedCentralPubMedGoogle Scholar
  89. 89.
    Hancox RJ, Poulton R, Greene JM, McLachlan CR, Pearce MS, Sears MR. Associations between birth weight, early childhood weight gain and adult lung function. Thorax. 2009;64(3):228–32.PubMedGoogle Scholar
  90. 90.
    Shi W, Bellusci S, Warburton D. Lung development and adult lung diseases. Chest. 2007;132(2):651–6. doi:10.1378/chest.06-2663.PubMedGoogle Scholar
  91. 91.
    Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ. 1991;303(6804):671–5.PubMedCentralPubMedGoogle Scholar
  92. 92.
    Haland G, Carlsen KC, Sandvik L, et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med. 2006;355(16):1682–9. doi:10.1056/NEJMoa052885.PubMedGoogle Scholar
  93. 93.
    Aysola RS, Hoffman EA, Gierada D, et al. Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology. Chest. 2008;134(6):1183–91. doi:10.1378/chest.07-2779.PubMedCentralPubMedGoogle Scholar
  94. 94.
    Castagnaro A, Rastelli A, Chetta A, et al. High-resolution computed tomography evaluation of airway distensibility in asthmatic and healthy subjects. Radiol Med. 2008;113(1):43–55. doi:10.1007/s11547-008-0223-3.PubMedGoogle Scholar
  95. 95.
    Grainge CL, Lau LC, Ward JA, et al. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med. 2011;364(21):2006–15. doi:10.1056/NEJMoa1014350.PubMedGoogle Scholar
  96. 96.
    Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011;378(9795):1015–26. doi:10.1016/S0140-6736(11)60988-4.PubMedGoogle Scholar
  97. 97.
    Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995;332(3):133–8. doi:10.1056/NEJM199501193320301.PubMedGoogle Scholar
  98. 98.
    Horak E, Lanigan A, Roberts M, et al. Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42. BMJ. 2003;326(7386):422–3. doi:10.1136/bmj.326.7386.422.PubMedCentralPubMedGoogle Scholar
  99. 99.
    Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med. 2003;349(15):1414–22. doi:10.1056/NEJMoa022363.PubMedGoogle Scholar
  100. 100.
    Illi S, von Mutius E, Lau S, et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet. 2006;368(9537):763–70. doi:10.1016/S0140-6736(06)69286-6.PubMedGoogle Scholar
  101. 101.
    Stern DA, Morgan WJ, Wright AL, Guerra S, Martinez FD. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet. 2007;370(9589):758–64. doi:10.1016/S0140-6736(07)61379-8.PubMedCentralPubMedGoogle Scholar
  102. 102.
    Stern DA, Morgan WJ, Halonen M, Wright AL, Martinez FD. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet. 2008;372(9643):1058–64. doi:10.1016/S0140-6736(08)61447-6.PubMedCentralPubMedGoogle Scholar
  103. 103.
    Harpsoe MC, Basit S, Bager P, et al. Maternal obesity, gestational weight gain, and risk of asthma and atopic disease in offspring: a study within the Danish National Birth Cohort. J Allergy Clin Immunol. 2013;131(4):1033–40. doi:10.1016/j.jaci.2012.09.008.PubMedGoogle Scholar
  104. 104.
    Leermakers ET, Sonnenschein-van der Voort AM, Gaillard R, et al. Maternal weight, gestational weight gain and preschool wheezing: the Generation R Study. Eur Respir J. 2013;42(5):1234–43. doi:10.1183/09031936.00148212.PubMedGoogle Scholar
  105. 105.
    Lazic N, Roberts G, Custovic A, et al. Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts. Allergy. 2013;68(6):764–70. doi:10.1111/all.12134.PubMedGoogle Scholar
  106. 106.
    Neuman A, Hohmann C, Orsini N, et al. Maternal smoking in pregnancy and asthma in preschool children: a pooled analysis of eight birth cohorts. Am J Respir Crit Care Med. 2012;186(10):1037–43. doi:10.1164/rccm.201203-0501OC.PubMedGoogle Scholar
  107. 107.
    Netting MJ, Middleton PF, Makrides M. Does maternal diet during pregnancy and lactation affect outcomes in offspring? A systematic review of food-based approaches. Nutrition. 2014;30(11–12):1225–41. doi:10.1016/j.nut.2014.02.015.PubMedGoogle Scholar
  108. 108.
    Caudri D, Wijga A, Gehring U, et al. Respiratory symptoms in the first 7 years of life and birth weight at term: the PIAMA Birth Cohort. Am J Respir Crit Care Med. 2007;175(10):1078–85.PubMedGoogle Scholar
  109. 109.
    Kindlund K, Thomsen SF, Stensballe LG, et al. Birth weight and risk of asthma in 3-9-year-old twins: exploring the fetal origins hypothesis. Thorax. 2010;65(2):146–9.PubMedGoogle Scholar
  110. 110.
    Taveras EM, Camargo CA Jr, Rifas-Shiman SL, et al. Association of birth weight with asthma-related outcomes at age 2 years. Pediatr Pulmonol. 2006;41(7):643–8.PubMedCentralPubMedGoogle Scholar
  111. 111.
    Yuan W, Basso O, Sorensen HT, Olsen J. Fetal growth and hospitalization with asthma during early childhood: a follow-up study in Denmark. Int J Epidemiol. 2002;31(6):1240–5.PubMedGoogle Scholar
  112. 112.
    Lawlor DA, Ebrahim S, Davey Smith G. Association of birth weight with adult lung function: findings from the British Women’s Heart and Health Study and a meta-analysis. Thorax. 2005;60(10):851–8.PubMedCentralPubMedGoogle Scholar
  113. 113.
    Lopuhaa CE, Roseboom TJ, Osmond C, et al. Atopy, lung function, and obstructive airways disease after prenatal exposure to famine. Thorax. 2000;55(7):555–61.PubMedCentralPubMedGoogle Scholar
  114. 114.
    Barker DJ. The intrauterine origins of cardiovascular and obstructive lung disease in adult life. The Marc Daniels Lecture 1990. J R Coll Physicians Lond. 1991;25(2):129–33.PubMedGoogle Scholar
  115. 115.
    Tennant PW, Gibson GJ, Parker L, Pearce MS. Childhood respiratory illness and lung function at ages 14 and 50 years: childhood respiratory illness and lung function. Chest. 2010;137(1):146–55. doi:10.1378/chest.09-0352.PubMedGoogle Scholar
  116. 116.
    Shaheen SO, Sterne JA, Tucker JS, Florey CD. Birth weight, childhood lower respiratory tract infection, and adult lung function. Thorax. 1998;53(7):549–53.PubMedCentralPubMedGoogle Scholar
  117. 117.
    Kotecha SJ, Watkins WJ, Heron J, Henderson J, Dunstan FD, Kotecha S. Spirometric lung function in school-age children: effect of intrauterine growth retardation and catch-up growth. Am J Respir Crit Care Med. 2010;181(9):969–74. doi:10.1164/rccm.200906-0897OC.PubMedCentralPubMedGoogle Scholar
  118. 118.
    Sonnenschein-van der Voort AM, Jaddoe VW, Raat H, et al. Fetal and infant growth and asthma symptoms in preschool children: the generation R study. Am J Respir Crit Care Med. 2012;185(7):731–7. doi:10.1164/rccm.201107-1266OC.PubMedGoogle Scholar
  119. 119.
    Sevelsted A, Bisgaard H. Neonatal size in term children is associated with asthma at age 7, but not with atopic dermatitis or allergic sensitization. Allergy. 2012;67(5):670–5. doi:10.1111/j.1398-9995.2012.02805.x.PubMedGoogle Scholar
  120. 120.
    Latzin P, Frey U, Roiha HL, et al. Prospectively assessed incidence, severity, and determinants of respiratory symptoms in the first year of life. Pediatr Pulmonol. 2007;42(1):41–50. doi:10.1002/ppul.20542.PubMedGoogle Scholar
  121. 121.
    Boyle EM, Poulsen G, Field DJ, et al. Effects of gestational age at birth on health outcomes at 3 and 5 years of age: population based cohort study. BMJ. 2012;344:e896. doi:10.1136/bmj.e896.PubMedCentralPubMedGoogle Scholar
  122. 122.
    Vogt H, Lindstrom K, Braback L, Hjern A. Preterm birth and inhaled corticosteroid use in 6- to 19-year-olds: a Swedish national cohort study. Pediatrics. 2011;127(6):1052–9. doi:10.1542/peds.2010-3083.PubMedGoogle Scholar
  123. 123.
    Jaakkola JJ, Ahmed P, Ieromnimon A, et al. Preterm delivery and asthma: a systematic review and meta-analysis. J Allergy Clin Immunol. 2006;118(4):823–30.PubMedGoogle Scholar
  124. 124.
    Been JV, Lugtenberg MJ, Smets E, et al. Preterm birth and childhood wheezing disorders: a systematic review and meta-analysis. PLoS medicine. 2014;11(1):e1001596. doi:10.1371/journal.pmed.1001596.PubMedCentralPubMedGoogle Scholar
  125. 125.
    Taal HR, Vd Heijden AJ, Steegers EA, Hofman A, Jaddoe VW. Small and large size for gestational age at birth, infant growth, and childhood overweight. Obesity. 2012;. doi:10.1002/oby.20116.Google Scholar
  126. 126.
    Pike KC, Crozier SR, Lucas JS, et al. Patterns of fetal and infant growth are related to atopy and wheezing disorders at age 3 years. Thorax. 2010;65(12):1099–106.PubMedCentralPubMedGoogle Scholar
  127. 127.
    Tai A, Volkmer R, Burton A. Association between asthma symptoms and obesity in preschool (4–5 year old) children. J Asthma. 2009;46(4):362–5.PubMedGoogle Scholar
  128. 128.
    Cadman RV, Lemanske RF Jr, Evans MD, et al. Pulmonary 3He magnetic resonance imaging of childhood asthma. J Allergy Clin Immunol. 2013;131(2):369–376. doi:10.1016/j.jaci.2012.10.032.PubMedCentralPubMedGoogle Scholar
  129. 129.
    Narayanan M, Owers-Bradley J, Beardsmore CS, et al. Alveolarization continues during childhood and adolescence: new evidence from helium-3 magnetic resonance. Am J Respir Crit Care Med. 2012;185(2):186–91. doi:10.1164/rccm.201107-1348OC.PubMedCentralPubMedGoogle Scholar
  130. 130.
    Kotecha S. Lung growth for beginners. Paediatr Respir Rev. 2000;1(4):308–13. doi:10.1053/prrv.2000.0069.PubMedGoogle Scholar
  131. 131.
    Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357(19):1946–55. doi:10.1056/NEJMra067279.PubMedGoogle Scholar
  132. 132.
    Colin AA, McEvoy C, Castile RG. Respiratory morbidity and lung function in preterm infants of 32 to 36 weeks’ gestational age. Pediatrics. 2010;126(1):115–28. doi:10.1542/peds.2009-1381.PubMedCentralPubMedGoogle Scholar
  133. 133.
    Kotecha SJ, Watkins WJ, Paranjothy S, Dunstan FD, Henderson AJ, Kotecha S. Effect of late preterm birth on longitudinal lung spirometry in school age children and adolescents. Thorax. 2012;67(1):54–61. doi:10.1136/thoraxjnl-2011-200329.PubMedGoogle Scholar
  134. 134.
    Jobe AH. An unknown: lung growth and development after very preterm birth. Am J Respir Crit Care Med. 2002;166(12 Pt 1):1529–30. doi:10.1164/rccm.2209012.PubMedGoogle Scholar
  135. 135.
    Friedrich L, Stein RT, Pitrez PM, Corso AL, Jones MH. Reduced lung function in healthy preterm infants in the first months of life. Am J Respir Crit Care Med. 2006;173(4):442–7. doi:10.1164/rccm.200503-444OC.PubMedGoogle Scholar
  136. 136.
    Hoo AF, Dezateux C, Henschen M, Costeloe K, Stocks J. Development of airway function in infancy after preterm delivery. J Pediatr. 2002;141(5):652–8. doi:10.1067/mpd.2002.128114.PubMedGoogle Scholar
  137. 137.
    Matias V, San Feliciano L, Fernandez JE, et al. Host and environmental factors influencing respiratory secretion of pro-wheezing biomarkers in preterm children. Pediatr Allergy Immunol. 2012;23(5):441–7. doi:10.1111/j.1399-3038.2012.01269.x.PubMedGoogle Scholar
  138. 138.
    Siltanen M, Wehkalampi K, Hovi P, et al. Preterm birth reduces the incidence of atopy in adulthood. J Allergy Clin Immunol. 2011;127(4):935–42. doi:10.1016/j.jaci.2010.12.1107.PubMedGoogle Scholar
  139. 139.
    Broughton S, Thomas MR, Marston L, et al. Very prematurely born infants wheezing at follow-up: lung function and risk factors. Arch Dis Child. 2007;92(9):776–80. doi:10.1136/adc.2006.112623.PubMedCentralPubMedGoogle Scholar
  140. 140.
    van Oosterhout AJ, Bloksma N. Regulatory T-lymphocytes in asthma. Eur Respir J. 2005;26(5):918–32. doi:10.1183/09031936.05.00011205.PubMedGoogle Scholar
  141. 141.
    Tang ML, Kemp AS, Thorburn J, Hill DJ. Reduced interferon-gamma secretion in neonates and subsequent atopy. Lancet. 1994;344(8928):983–5.PubMedGoogle Scholar
  142. 142.
    Sly PD, Holt PG. Role of innate immunity in the development of allergy and asthma. Curr Opin Allergy Clin Immunol. 2011;11(2):127–31. doi:10.1097/ACI.0b013e32834487c6.PubMedGoogle Scholar
  143. 143.
    Gimeno D, Delclos GL, Ferrie JE, et al. Association of CRP and IL-6 with lung function in a middle-aged population initially free from self-reported respiratory problems: the Whitehall II study. Eur J Epidemiol. 2011;26(2):135–44. doi:10.1007/s10654-010-9526-5.PubMedCentralPubMedGoogle Scholar
  144. 144.
    Duijts L, Jaddoe VW, van der Valk RJ, Henderson AJ, Hofman A, Raat H, Steegers EA, Moll HA, de Jongste JC. Fetal exposure to maternal and paternal smoking and the risks of wheezing in preschool children. The Generation R Study. Chest. 2012;141(4):876–85. doi:10.1378/chest.11-0112
  145. 145.
    Kumar R, Yu Y, Story RE, et al. Prematurity, chorioamnionitis, and the development of recurrent wheezing: a prospective birth cohort study. J Allergy Clin Immunol. 2008;121(4):878–84. doi:10.1016/j.jaci.2008.01.030.PubMedCentralPubMedGoogle Scholar
  146. 146.
    Hallman M, Marttila R, Pertile R, Ojaniemi M, Haataja R. Genes and environment in common neonatal lung disease. Neonatology. 2007;91(4):298–302. doi:10.1159/000101345.PubMedGoogle Scholar
  147. 147.
    Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548–56. doi:10.1210/jc.2004-0395.PubMedGoogle Scholar
  148. 148.
    Shore SA, Schwartzman IN, Mellema MS, Flynt L, Imrich A, Johnston RA. Effect of leptin on allergic airway responses in mice. J Allergy Clin Immunol. 2005;115(1):103–9. doi:10.1016/j.jaci.2004.10.007.PubMedGoogle Scholar
  149. 149.
    Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med. 2006;174(2):112–9. doi:10.1164/rccm.200602-231PP.PubMedCentralPubMedGoogle Scholar
  150. 150.
    Inskip HM, Godfrey KM, Robinson SM, et al. Cohort profile: The Southampton Women’s Survey. Int J Epidemiol. 2006;35(1):42–8. doi:10.1093/ije/dyi202.PubMedGoogle Scholar
  151. 151.
    Jaddoe VW, van Duijn CM, van der Heijden AJ, et al. The Generation R Study: design and cohort update 2010. Eur J Epidemiol. 2010;. doi:10.1007/s10654-010-9516-7.Google Scholar
  152. 152.
    Pike KC, Crozier SR, Lucas JS, et al. Patterns of fetal and infant growth are related to atopy and wheezing disorders at age 3 years. Thorax. 2010;65(12):1099–106. doi:10.1136/thx.2010.134742
  153. 153.
    Turner S, Prabhu N, Danielan P, et al. First- and second-trimester fetal size and asthma outcomes at age 10 years. Am J Respir Crit Care Med. 2011;184(4):407–13. doi:10.1164/rccm.201012-2075OC.PubMedGoogle Scholar
  154. 154.
    Sonnenschein-van der Voort AM, Jaddoe VW, Raat H, et al. Fetal and infant growth and asthma symptoms in preschool children. The Generation R Study. Am J Respir Crit Care Med. 2012;. doi:10.1164/rccm.201107-1266OC.PubMedGoogle Scholar
  155. 155.
    Patel SP, Rodriguez A, Little MP, et al. Associations between pre-pregnancy obesity and asthma symptoms in adolescents. J Epidemiol Community Health. 2011;. doi:10.1136/jech.2011.133777.PubMedCentralGoogle Scholar
  156. 156.
    Lowe A, Braback L, Ekeus C, Hjern A, Forsberg B. Maternal obesity during pregnancy as a risk for early-life asthma. J Allergy Clin Immunol. 2011;. doi:10.1016/j.jaci.2011.08.025.Google Scholar
  157. 157.
    Schachter LM, Salome CM, Peat JK, Woolcock AJ. Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Thorax. 2001;56(1):4–8.PubMedCentralPubMedGoogle Scholar
  158. 158.
    Lowe A, Braback L, Ekeus C, Hjern A, Forsberg B. Maternal obesity during pregnancy as a risk for early-life asthma. J Allergy Clin Immunol. 2011;128(5):1107–9. doi:10.1016/j.jaci.2011.08.025.PubMedGoogle Scholar
  159. 159.
    Forno E, Young OM, Kumar R, Simhan H, Celedon JC. Maternal obesity in pregnancy, gestational weight gain, and risk of childhood asthma. Pediatrics. 2014;134(2):e535–46. doi:10.1542/peds.2014-0439.PubMedGoogle Scholar
  160. 160.
    Shaheen SO. Prenatal nutrition and asthma: hope or hype? Thorax. 2008;63(6):483–5. doi:10.1136/thx.2007.090019.PubMedGoogle Scholar
  161. 161.
    Whitrow MJ, Moore VM, Rumbold AR, Davies MJ. Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am J Epidemiol. 2009;170(12):1486–93. doi:10.1093/aje/kwp315.PubMedGoogle Scholar
  162. 162.
    Haberg SE, London SJ, Stigum H, Nafstad P, Nystad W. Folic acid supplements in pregnancy and early childhood respiratory health. Arch Dis Child. 2009;94(3):180–4. doi:10.1136/adc.2008.142448.PubMedCentralPubMedGoogle Scholar
  163. 163.
    Turner SW, Campbell D, Smith N, et al. Associations between fetal size, maternal {alpha}-tocopherol and childhood asthma. Thorax. 2010;65(5):391–7. doi:10.1136/thx.2008.111385.PubMedGoogle Scholar
  164. 164.
    Shaheen SO, Northstone K, Newson RB, Emmett PM, Sherriff A, Henderson AJ. Dietary patterns in pregnancy and respiratory and atopic outcomes in childhood. Thorax. 2009;64(5):411–7. doi:10.1136/thx.2008.104703.PubMedGoogle Scholar
  165. 165.
    Scholtens S, Wijga AH, Brunekreef B, et al. Maternal overweight before pregnancy and asthma in offspring followed for 8 years. Int J Obes (Lond). 2010;34(4):606–13. doi:10.1038/ijo.2009.194.Google Scholar
  166. 166.
    Nagel G, Weinmayr G, Kleiner A, Garcia-Marcos L, Strachan DP. Effect of diet on asthma and allergic sensitisation in the International Study on Allergies and Asthma in Childhood (ISAAC) Phase Two. Thorax. 2010;65(6):516–22. doi:10.1136/thx.2009.128256.PubMedGoogle Scholar
  167. 167.
    Granell R, Heron J, Lewis S, Davey Smith G, Sterne JA, Henderson J. The association between mother and child MTHFR C677T polymorphisms, dietary folate intake and childhood atopy in a population-based, longitudinal birth cohort. Clin Exp Allergy. 2008;38(2):320–8. doi:10.1111/j.1365-2222.2007.02902.x.PubMedGoogle Scholar
  168. 168.
    Heppe DH, Steegers EA, Timmermans S, et al. Maternal fish consumption, fetal growth and the risks of neonatal complications: the Generation R Study. Br J Nutr. 2011;105(6):938–49. doi:10.1017/S0007114510004460.PubMedGoogle Scholar
  169. 169.
    Stein AD, Ravelli AC, Lumey LH. Famine, third-trimester pregnancy weight gain, and intrauterine growth: the Dutch Famine Birth Cohort Study. Hum Biol. 1995;67(1):135–50.PubMedGoogle Scholar
  170. 170.
    Leermakers ET, Sonnenschein-van der Voort AM, Heppe DH, et al. Maternal fish consumption during pregnancy and risks of wheezing and eczema in childhood: the Generation R Study. Eur J Clin Nutr. 2013;67(4):353–9. doi:10.1038/ejcn.2013.36.PubMedGoogle Scholar
  171. 171.
    Black PN, Sharpe S. Dietary fat and asthma: is there a connection? Eur Respir J. 1997;10(1):6–12.PubMedGoogle Scholar
  172. 172.
    Calder PC, Kremmyda LS, Vlachava M, Noakes PS, Miles EA. Is there a role for fatty acids in early life programming of the immune system? Proc Nutr Soc. 2010;69(3):373–80.PubMedGoogle Scholar
  173. 173.
    Prescott SL, Dunstan JA. Prenatal fatty acid status and immune development: the pathways and the evidence. Lipids. 2007;42(9):801–10.PubMedGoogle Scholar
  174. 174.
    Mickleborough TD, Rundell KW. Dietary polyunsaturated fatty acids in asthma- and exercise-induced bronchoconstriction. Eur J Clin Nutr. 2005;59(12):1335–46.PubMedGoogle Scholar
  175. 175.
    Wendell SG, Baffi C, Holguin F. Fatty acids, inflammation, and asthma. J Allergy Clin Immunol. 2014;133(5):1255–64.PubMedGoogle Scholar
  176. 176.
    Notenboom ML, Mommers M, Jansen EH, Penders J, Thijs C. Maternal fatty acid status in pregnancy and childhood atopic manifestations: KOALA Birth Cohort Study. Clin Exp Allergy. 2011;41(3):407–16.PubMedGoogle Scholar
  177. 177.
    Nwaru BI, Erkkola M, Lumia M, et al. Maternal intake of fatty acids during pregnancy and allergies in the offspring. Br J Nutr. 2012;108(4):720–32.PubMedGoogle Scholar
  178. 178.
    Miyake Y, Tanaka K, Okubo H, Sasaki S, Arakawa M. Maternal fat intake during pregnancy and wheeze and eczema in Japanese infants: the Kyushu Okinawa Maternal and Child Health Study. Ann Epidemiol. 2013;23(11):674–80.PubMedGoogle Scholar
  179. 179.
    Pike KC, Calder Pc Fau-Inskip HM, Inskip Hm Fau-Robinson SM, et al. Maternal plasma phosphatidylcholine fatty acids and atopy and wheeze in the offspring at age of 6 years. (1740-2530 (Electronic)).Google Scholar
  180. 180.
    Maslova E, Halldorsson TI, Strom M, Olsen SF. Low-fat yoghurt intake in pregnancy associated with increased child asthma and allergic rhinitis risk: a prospective cohort study. J Nutr Sci. 2012;1:e5.PubMedCentralPubMedGoogle Scholar
  181. 181.
    Barman M, Johansson S, Hesselmar B, Wold AE, Sandberg AS, Sandin A. High levels of both n-3 and n-6 long-chain polyunsaturated fatty acids in cord serum phospholipids predict allergy development. PLoS ONE. 2013;8(7):e67920.PubMedCentralPubMedGoogle Scholar
  182. 182.
    Montes R, Chisaguano AM, Castellote AI, Morales E, Sunyer J, Lopez-Sabater MC. Fatty-acid composition of maternal and umbilical cord plasma and early childhood atopic eczema in a Spanish cohort. Eur J Clin Nutr. 2013;67(6):658–63.PubMedGoogle Scholar
  183. 183.
    Heijmans BT, Tobi EW, Stein AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA. 2008;105(44):17046–9. doi:10.1073/pnas.0806560105.PubMedCentralPubMedGoogle Scholar
  184. 184.
    Tobi EW, Heijmans BT, Kremer D, et al. DNA methylation of IGF2, GNASAS, INSIGF and LEP and being born small for gestational age. Epigenetics. 2011;6(2):171–6.PubMedCentralPubMedGoogle Scholar
  185. 185.
    Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, et al. Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS ONE. 2009;4(11):e7845. doi:10.1371/journal.pone.0007845.PubMedCentralPubMedGoogle Scholar
  186. 186.
    Camargo CA Jr, Rifas-Shiman SL, Litonjua AA, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr. 2007;85(3):788–95.PubMedGoogle Scholar
  187. 187.
    Devereux G, Litonjua AA, Turner SW, et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr. 2007;85(3):853–9.PubMedGoogle Scholar
  188. 188.
    Miyake Y, Sasaki S, Tanaka K, Hirota Y. Maternal B vitamin intake during pregnancy and wheeze and eczema in Japanese infants aged 16-24 months: the Osaka Maternal and Child Health Study. Pediatr Allergy Immunol. 2011;22(1 Pt 1):69–74. doi:10.1111/j.1399-3038.2010.01081.x.PubMedGoogle Scholar
  189. 189.
    Erkkola M, Kaila M, Nwaru BI, et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy. 2009;39(6):875–82. doi:10.1111/j.1365-2222.2009.03234.x.PubMedGoogle Scholar
  190. 190.
    Sundar IK, Rahman I. Vitamin d and susceptibility of chronic lung diseases: role of epigenetics. Front Pharmacol. 2011;2:50. doi:10.3389/fphar.2011.00050.PubMedCentralPubMedGoogle Scholar
  191. 191.
    Gaillard R, Steegers EA, Tiemeier H, Hofman A, Jaddoe VW. Placental vascular dysfunction, fetal and childhood growth, and cardiovascular development: the generation R study. Circulation. 2013;128(20):2202–10. doi:10.1161/CIRCULATIONAHA.113.003881.PubMedGoogle Scholar
  192. 192.
    Kramer MS, Vanilovich I, Matush L, et al. The effect of prolonged and exclusive breast-feeding on dental caries in early school-age children. New evidence from a large randomized trial. Caries Res. 2007;41(6):484–8. doi:10.1159/000108596.PubMedGoogle Scholar
  193. 193.
    Sears MR, Greene JM, Willan AR, et al. Long-term relation between breastfeeding and development of atopy and asthma in children and young adults: a longitudinal study. Lancet. 2002;360(9337):901–7. doi:10.1016/S0140-6736(02)11025-7.PubMedGoogle Scholar
  194. 194.
    Sonnenschein-van der Voort AM, Jaddoe VV, van der Valk RJ, et al. Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms. Eur Respir J. 2011;. doi:10.1183/09031936.00178110.PubMedGoogle Scholar
  195. 195.
    Elliott L, Henderson J, Northstone K, Chiu GY, Dunson D, London SJ. Prospective study of breast-feeding in relation to wheeze, atopy, and bronchial hyperresponsiveness in the Avon Longitudinal Study of Parents and Children (ALSPAC). J Allergy Clin Immunol. 2008;122(1):49–54. doi:10.1016/j.jaci.2008.04.001.PubMedCentralPubMedGoogle Scholar
  196. 196.
    Fisk CM, Crozier SR, Inskip HM, et al. Breastfeeding and reported morbidity during infancy: findings from the Southampton Women’s Survey. Matern Child Nutr. 2011;7(1):61–70. doi:10.1111/j.1740-8709.2010.00241.x.PubMedGoogle Scholar
  197. 197.
    Dogaru CM, Nyffenegger D, Pescatore AM, Spycher BD, Kuehni CE. Breastfeeding and childhood asthma: systematic review and meta-analysis. Am J Epidemiol. 2014;179(10):1153–67. doi:10.1093/aje/kwu072.PubMedGoogle Scholar
  198. 198.
    Friedman NJ, Zeiger RS. The role of breast-feeding in the development of allergies and asthma. J Allergy Clin Immunol. 2005;115(6):1238–48. doi:10.1016/j.jaci.2005.01.069.PubMedGoogle Scholar
  199. 199.
    Newburg DS. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci. 2009;87(13 Suppl):26–34. doi:10.2527/jas.2008-1347.PubMedGoogle Scholar
  200. 200.
    Hoppu U, Kalliomaki M, Laiho K, Isolauri E. Breast milk-immunomodulatory signals against allergic diseases. Allergy. 2001;56(Suppl 67):23–6.PubMedGoogle Scholar
  201. 201.
    Scholtens S, Wijga AH, Brunekreef B, et al. Breast feeding, parental allergy and asthma in children followed for 8 years. The PIAMA birth cohort study. Thorax. 2009;64(7):604–9. doi:10.1136/thx.2007.094938.PubMedGoogle Scholar
  202. 202.
    Rothenbacher D, Weyermann M, Beermann C, Brenner H. Breastfeeding, soluble CD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: birth cohort study. Clin Exp Allergy. 2005;35(8):1014–21. doi:10.1111/j.1365-2222.2005.02298.x.PubMedGoogle Scholar
  203. 203.
    Durmus B, van Rossem L, Duijts L, et al. Breast-feeding and growth in children until the age of 3 years: the Generation R Study. Br J Nutr. 2011;105(11):1704–11. doi:10.1017/S0007114510005374.PubMedGoogle Scholar
  204. 204.
    Mook-Kanamori DO, Steegers EA, Uitterlinden AG, et al. Breast-feeding modifies the association of PPARgamma2 polymorphism Pro12Ala with growth in early life: the Generation R Study. Diabetes. 2009;58(4):992–8. doi:10.2337/db08-1311.PubMedCentralPubMedGoogle Scholar
  205. 205.
    Burke H, Leonardi-Bee J, Hashim A, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics. 2012;129(4):735–44. doi:10.1542/peds.2011-2196.PubMedGoogle Scholar
  206. 206.
    Haberg SE, Stigum H, Nystad W, Nafstad P. Effects of pre- and postnatal exposure to parental smoking on early childhood respiratory health. Am J Epidemiol. 2007;166(6):679–86. doi:10.1093/aje/kwm134.PubMedGoogle Scholar
  207. 207.
    Gilliland FD, Berhane K, Li YF, Rappaport EB, Peters JM. Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function. Am J Respir Crit Care Med. 2003;167(6):917–24. doi:10.1164/rccm.200206-616OC.PubMedGoogle Scholar
  208. 208.
    Lux AL, Henderson AJ, Pocock SJ. Wheeze associated with prenatal tobacco smoke exposure: a prospective, longitudinal study. ALSPAC Study Team. Arch Dis Child. 2000;83(4):307–12.PubMedCentralPubMedGoogle Scholar
  209. 209.
    Lannero E, Wickman M, Pershagen G, Nordvall L. Maternal smoking during pregnancy increases the risk of recurrent wheezing during the first years of life (BAMSE). Respir Res. 2006;7:3. doi:10.1186/1465-9921-7-3.PubMedCentralPubMedGoogle Scholar
  210. 210.
    Magnusson LL, Olesen AB, Wennborg H, Olsen J. Wheezing, asthma, hayfever, and atopic eczema in childhood following exposure to tobacco smoke in fetal life. Clin Exp Allergy. 2005;35(12):1550–6. doi:10.1111/j.1365-2222.2005.02374.x.PubMedGoogle Scholar
  211. 211.
    Stein RT, Holberg CJ, Sherrill D, et al. Influence of parental smoking on respiratory symptoms during the first decade of life: the Tucson Children’s Respiratory Study. Am J Epidemiol. 1999;149(11):1030–7.PubMedGoogle Scholar
  212. 212.
    Prabhu N, Smith N, Campbell D, et al. First trimester maternal tobacco smoking habits and fetal growth. Thorax. 2010;65(3):235–40. doi:10.1136/thx.2009.123232.PubMedGoogle Scholar
  213. 213.
    Duijts L, Jaddoe VW, van der Valk RJ, et al. Fetal exposure to maternal and paternal smoking and the risks of wheezing in preschool children: the Generation R Study. Chest. 2012;141(4):876–85. doi:10.1378/chest.11-0112.PubMedGoogle Scholar
  214. 214.
    Schraufnagel DE, Blasi F, Drummond MB, et al. Electronic cigarettes. A position statement of the forum of international respiratory societies. Am J Respir Crit Care Med. 2014;190(6):611–8. doi:10.1164/rccm.201407-1198PP.PubMedGoogle Scholar
  215. 215.
    van der Gugten A, Korte K, van der Ent K, Uiterwaal C, Verheij T. Small airway caliber is the most important contributor of wheezing in healthy unselected newborns. Am J Respir Crit Care Med. 2011;183(4):553; author reply-4. doi:10.1164/ajrccm.183.4.553a.
  216. 216.
    Rasmussen F, Taylor DR, Flannery EM, et al. Risk factors for hospital admission for asthma from childhood to young adulthood: a longitudinal population study. J Allergy Clin Immunol. 2002;110(2):220–7.PubMedGoogle Scholar
  217. 217.
    Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364(9435):709–21. doi:10.1016/S0140-6736(04)16900-6.PubMedGoogle Scholar
  218. 218.
    Sekhon HS, Jia Y, Raab R, et al. Prenatal nicotine increases pulmonary alpha7 nicotinic receptor expression and alters fetal lung development in monkeys. J Clin Investig. 1999;103(5):637–47. doi:10.1172/JCI5232.PubMedCentralPubMedGoogle Scholar
  219. 219.
    Bisgaard H, Jensen SM, Bonnelykke K. Interaction between asthma and lung function growth in early life. Am J Respir Crit Care Med. 2012;185(11):1183–9. doi:10.1164/rccm.201110-1922OC.PubMedGoogle Scholar
  220. 220.
    Haland G, Carlsen KC, Sandvik L, et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med. 2006;355(16):1682–9. doi:10.1056/NEJMoa052885.PubMedGoogle Scholar
  221. 221.
    Stocks J, Sonnappa S. Early life influences on the development of chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2013;7(3):161–73. doi:10.1177/1753465813479428.PubMedCentralPubMedGoogle Scholar
  222. 222.
    Moshammer H, Hoek G, Luttmann-Gibson H, et al. Parental smoking and lung function in children: an international study. Am J Respir Crit Care Med. 2006;173(11):1255–63. doi:10.1164/rccm.200510-1552OC.PubMedGoogle Scholar
  223. 223.
    McEvoy CT, Schilling D, Clay N, et al. Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial. JAMA. 2014;311(20):2074–82. doi:10.1001/jama.2014.5217.PubMedGoogle Scholar
  224. 224.
    Bouzigon E, Corda E, Aschard H, et al. Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med. 2008;359(19):1985–94. doi:10.1056/NEJMoa0806604.PubMedGoogle Scholar
  225. 225.
    Martino D, Prescott S. Epigenetics and prenatal influences on asthma and allergic airways disease. Chest. 2011;139(3):640–7. doi:10.1378/chest.10-1800.PubMedGoogle Scholar
  226. 226.
    Breton CV, Byun HM, Wenten M, Pan F, Yang A, Gilliland FD. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med. 2009;180(5):462–7. doi:10.1164/rccm.200901-0135OC.PubMedCentralPubMedGoogle Scholar
  227. 227.
    Flory JH, Sleiman PM, Christie JD, et al. 17q12-21 variants interact with smoke exposure as a risk factor for pediatric asthma but are equally associated with early-onset versus late-onset asthma in North Americans of European ancestry. J Allergy Clin Immunol. 2009;124(3):605–7. doi:10.1016/j.jaci.2009.05.047.PubMedGoogle Scholar
  228. 228.
    Morales E, Bustamante M, Vilahur N, et al. DNA hypomethylation at ALOX12 is associated with persistent wheezing in childhood. Am J Respir Crit Care Med. 2012;185(9):937–43. doi:10.1164/rccm.201105-0870OC.PubMedGoogle Scholar
  229. 229.
    Rhodes HL, Sporik R, Thomas P, Holgate ST, Cogswell JJ. Early life risk factors for adult asthma: a birth cohort study of subjects at risk. J Allergy Clin Immunol. 2001;108(5):720–5. doi:10.1067/mai.2001.119151.PubMedGoogle Scholar
  230. 230.
    Torrent M, Sunyer J, Garcia R, et al. Early-life allergen exposure and atopy, asthma, and wheeze up to 6 years of age. Am J Respir Crit Care Med. 2007;176(5):446–53. doi:10.1164/rccm.200607-916OC.PubMedGoogle Scholar
  231. 231.
    Simpson A, Tan VY, Winn J, et al. Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study. Am J Respir Crit Care Med. 2010;181(11):1200–6. doi:10.1164/rccm.200907-1101OC.PubMedGoogle Scholar
  232. 232.
    Roberts G, Zhang H, Karmaus W, et al. Trends in cutaneous sensitization in the first 18 years of life: results from the 1989 Isle of Wight birth cohort study. Clin Exp Allergy. 2012;42(10):1501–9. doi:10.1111/j.1365-2222.2012.04074.x.PubMedGoogle Scholar
  233. 233.
    Garden FL, Simpson JM, Marks GB, Investigators C. Atopy phenotypes in the Childhood Asthma Prevention Study (CAPS) cohort and the relationship with allergic disease: clinical mechanisms in allergic disease. Clin Exp Allergy. 2013;43(6):633–41. doi:10.1111/cea.12095.PubMedGoogle Scholar
  234. 234.
    Custovic A. To what extent is allergen exposure a risk factor for the development of allergic disease? Clin Exp Allergy. 2014;. doi:10.1111/cea.12450.PubMedGoogle Scholar
  235. 235.
    Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet. 2001;358(9288):1129–33. doi:10.1016/S0140-6736(01)06252-3.PubMedGoogle Scholar
  236. 236.
    Friedlander SL, Jackson DJ, Gangnon RE, et al. Viral infections, cytokine dysregulation and the origins of childhood asthma and allergic diseases. Pediatr Infect Dis J. 2005;24(11 Suppl):S170-6, discussion S4-5.Google Scholar
  237. 237.
    Bisgaard H, Hermansen MN, Bonnelykke K, et al. Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ. 2010;341:c4978.PubMedCentralPubMedGoogle Scholar
  238. 238.
    Bisgaard H, Hermansen MN, Buchvald F, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med. 2007;357(15):1487–95. doi:10.1056/NEJMoa052632.PubMedGoogle Scholar
  239. 239.
    Ege MJ, Mayer M, Normand AC, et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med. 2011;364(8):701–9. doi:10.1056/NEJMoa1007302.PubMedGoogle Scholar
  240. 240.
    Shaheen SO, Barker DJ, Holgate ST. Do lower respiratory tract infections in early childhood cause chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 1995;151(5):1649–51; discussion 51-2.Google Scholar
  241. 241.
    Schnabel E, Heinrich J, Group LS. Respiratory tract infections and not paracetamol medication during infancy are associated with asthma development in childhood. J Allergy Clin Immunol. 2010;126(5):1071–3. doi:10.1016/j.jaci.2010.08.023.PubMedGoogle Scholar
  242. 242.
    Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax. 2010;65(1):14–20. doi:10.1136/thx.2008.112136.PubMedGoogle Scholar
  243. 243.
    Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354(9178):541–5. doi:10.1016/S0140-6736(98)10321-5.PubMedGoogle Scholar
  244. 244.
    Kusel MM, de Klerk NH, Kebadze T, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007;119(5):1105–10. doi:10.1016/j.jaci.2006.12.669.PubMedGoogle Scholar
  245. 245.
    Regnier SA, Huels J. Association between respiratory syncytial virus hospitalizations in infants and respiratory sequelae: systematic review and meta-analysis. Pediatr Infect Dis J. 2013;32(8):820–6. doi:10.1097/INF.0b013e31829061e8.PubMedGoogle Scholar
  246. 246.
    Holt PG, Strickland DH, Hales BJ, Sly PD. Defective respiratory tract immune surveillance in asthma: a primary causal factor in disease onset and progression. Chest. 2014;145(2):370–8. doi:10.1378/chest.13-1341.PubMedGoogle Scholar
  247. 247.
    Blanken MO, Rovers MM, Molenaar JM, et al. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. New Engl J Med. 2013;368(19):1791–9. doi:10.1056/NEJMoa1211917.PubMedGoogle Scholar
  248. 248.
    Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178(7):667–72. doi:10.1164/rccm.200802-309OC.PubMedCentralPubMedGoogle Scholar
  249. 249.
    Caliskan M, Bochkov YA, Kreiner-Moller E, et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. New Engl J Med. 2013;368(15):1398–407. doi:10.1056/NEJMoa1211592.PubMedCentralPubMedGoogle Scholar
  250. 250.
    Stokholm J, Sevelsted A, Bonnelykke K, Bisgaard H. Maternal propensity for infections and risk of childhood asthma: a registry-based cohort study. Lancet Respir Med. 2014;2(8):631–7. doi:10.1016/S2213-2600(14)70152-3.PubMedGoogle Scholar
  251. 251.
    Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun. 2006;7(2):95–100.PubMedGoogle Scholar
  252. 252.
    Hall IP, Blakey JD, Al Balushi KA, et al. Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study. Lancet. 2006;368(9537):771–9. doi:10.1016/S0140-6736(06)69287-8.PubMedGoogle Scholar
  253. 253.
    Noguchi E, Sakamoto H, Hirota T, et al. Genome-wide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populations. PLoS Genet. 2011;7(7):e1002170. doi:10.1371/journal.pgen.1002170.PubMedCentralPubMedGoogle Scholar
  254. 254.
    Hancock DB, Romieu I, Shi M, et al. Genome-wide association study implicates chromosome 9q21.31 as a susceptibility locus for asthma in mexican children. PLoS Genet. 2009;5(8):e1000623. doi:10.1371/journal.pgen.1000623.PubMedCentralPubMedGoogle Scholar
  255. 255.
    Mexico City Childhood Asthma Study, Torgerson DG, Ampleford EJ. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet. 2011;. doi:10.1038/ng.888.PubMedCentralGoogle Scholar
  256. 256.
    Hirota T, Takahashi A, Kubo M, et al. Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet. 2011;. doi:10.1038/ng.887.PubMedGoogle Scholar
  257. 257.
    Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363(13):1211–21.PubMedCentralPubMedGoogle Scholar
  258. 258.
    Sleiman PM, Flory J, Imielinski M, et al. Variants of DENND1B associated with asthma in children. N Engl J Med. 2010;362(1):36–44. doi:10.1056/NEJMoa0901867.PubMedGoogle Scholar
  259. 259.
    Ferreira MA, Matheson MC, Duffy DL, et al. Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet. 2011;378(9795):1006–14. doi:10.1016/S0140-6736(11)60874-X.PubMedCentralPubMedGoogle Scholar
  260. 260.
    Forno E, Lasky-Su J, Himes B, et al. Genome-wide association study of the age of onset of childhood asthma. J Allergy Clin Immunol. 2012;130(1):83–90. doi:10.1016/j.jaci.2012.03.020.PubMedCentralPubMedGoogle Scholar
  261. 261.
    Bonnelykke K, Sleiman P, Nielsen K, et al. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet. 2014;46(1):51–5. doi:10.1038/ng.2830.PubMedGoogle Scholar
  262. 262.
    van der Valk RJ, Duijts L, Kerkhof M, et al. Interaction of a 17q12 variant with both fetal and infant smoke exposure in the development of childhood asthma-like symptoms: epidemiology and Genetics. Allergy. 2012;. doi:10.1111/j.1398-9995.2012.02819.x.Google Scholar
  263. 263.
    Cho MH, McDonald ML, Zhou X, et al. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med. 2014;2(3):214–25. doi:10.1016/S2213-2600(14)70002-5.PubMedGoogle Scholar
  264. 264.
    Loth DW, Artigas MS, Gharib SA, et al. Genome-wide association analysis identifies six new loci associated with forced vital capacity. Nat Genet. 2014;46(7):669–77. doi:10.1038/ng.3011.PubMedGoogle Scholar
  265. 265.
    Imboden M, Bouzigon E, Curjuric I, et al. Genome-wide association study of lung function decline in adults with and without asthma. J Allergy Clin Immunol. 2012;129(5):1218–28. doi:10.1016/j.jaci.2012.01.074.PubMedCentralPubMedGoogle Scholar
  266. 266.
    Tang W, Kowgier M, Loth DW, et al. Large-scale genome-wide association studies and meta-analyses of longitudinal change in adult lung function. PLoS ONE. 2014;9(7):e100776. doi:10.1371/journal.pone.0100776.PubMedCentralPubMedGoogle Scholar
  267. 267.
    Hansel NN, Ruczinski I, Rafaels N, et al. Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD. Hum Genet. 2013;132(1):79–90. doi:10.1007/s00439-012-1219-6.PubMedCentralPubMedGoogle Scholar
  268. 268.
    Martinez FD, Vercelli D. Asthma. Lancet. 2013;382(9901):1360–72. doi:10.1016/S0140-6736(13)61536-6.PubMedGoogle Scholar
  269. 269.
    Murdzoska J, Devadason SG, Khoo SK, et al. In utero smoke exposure and role of maternal and infant glutathione s-transferase genes on airway responsiveness and lung function in infancy. Am J Respir Crit Care Med. 2010;181(1):64–71. doi:10.1164/rccm.200812-1887OC.PubMedGoogle Scholar
  270. 270.
    Meyers DA, Postma DS, Stine OC, et al. Genome screen for asthma and bronchial hyperresponsiveness: interactions with passive smoke exposure. J Allergy Clin Immunol. 2005;115(6):1169–75. doi:10.1016/j.jaci.2005.01.070.PubMedGoogle Scholar
  271. 271.
    Panasevich S, Lindgren C, Kere J, et al. Interaction between early maternal smoking and variants in TNF and GSTP1 in childhood wheezing. Clin Exp Allergy. 2010;40(3):458–67. doi:10.1111/j.1365-2222.2010.03452.x.PubMedGoogle Scholar
  272. 272.
    Schultz EN, Devadason SG, Khoo SK, et al. The role of GSTP1 polymorphisms and tobacco smoke exposure in children with acute asthma. J Asthma. 2010;47(9):1049–56. doi:10.1080/02770903.2010.508856.PubMedGoogle Scholar
  273. 273.
    Mestdagh P, Vandesompele J, Brusselle G, Vermaelen K. Non-coding RNAs and respiratory disease. Thorax. 2014;. doi:10.1136/thoraxjnl-2014-206404.PubMedGoogle Scholar
  274. 274.
    Obermann-Borst SA, Eilers PH, Tobi EW, et al. Duration of breastfeeding and gender are associated with methylation of the LEPTIN gene in very young children. Pediatr Res. 2013;74(3):344–9. doi:10.1038/pr.2013.95.PubMedGoogle Scholar
  275. 275.
    Fu A, Leaderer BP, Gent JF, Leaderer D, Zhu Y. An environmental epigenetic study of ADRB2 5’-UTR methylation and childhood asthma severity. Clin Exp Allergy. 2012;42(11):1575–81. doi:10.1111/j.1365-2222.2012.04055.x.PubMedCentralPubMedGoogle Scholar
  276. 276.
    Breton CV, Siegmund KD, Joubert BR, et al. Prenatal tobacco smoke exposure is associated with childhood DNA CpG methylation. PLoS ONE. 2014;9(6):e99716. doi:10.1371/journal.pone.0099716.PubMedCentralPubMedGoogle Scholar
  277. 277.
    Joubert BR, Haberg SE, Nilsen RM, et al. 450 K epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ Health Perspect. 2012;120(10):1425–31. doi:10.1289/ehp.1205412.PubMedCentralPubMedGoogle Scholar
  278. 278.
    Patil VK, Holloway JW, Zhang H, et al. Interaction of prenatal maternal smoking, interleukin 13 genetic variants and DNA methylation influencing airflow and airway reactivity. Clin Epigenetics. 2013;5(1):22. doi:10.1186/1868-7083-5-22.PubMedCentralPubMedGoogle Scholar
  279. 279.
    Qiu W, Baccarelli A, Carey VJ, et al. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med. 2012;185(4):373–81. doi:10.1164/rccm.201108-1382OC.PubMedCentralPubMedGoogle Scholar
  280. 280.
    Lepeule J, Baccarelli A, Motta V, et al. Gene promoter methylation is associated with lung function in the elderly: The Normative Aging Study. Epigenetics. 2012;7(3):261–9. doi:10.4161/epi.7.3.19216.PubMedCentralPubMedGoogle Scholar
  281. 281.
    Sood A, Petersen H, Blanchette CM, et al. Methylated genes in sputum among older smokers with asthma. Chest. 2012;. doi:10.1378/chest.11-2519.PubMedCentralPubMedGoogle Scholar
  282. 282.
    Breton CV, Byun HM, Wang X, Salam MT, Siegmund K, Gilliland FD. DNA methylation in the arginase-nitric oxide synthase pathway is associated with exhaled nitric oxide in children with asthma. Am J Respir Crit Care Med. 2011;184(2):191–7. doi:10.1164/rccm.201012-2029OC.PubMedCentralPubMedGoogle Scholar
  283. 283.
    Morales E, Bustamante M, Vilahur N, et al. DNA hypomethylation at ALOX12 is associated with persistent wheezing in childhood. Am J Respir Crit Care Med. 2012;. doi:10.1164/rccm.201105-0870OC.PubMedCentralGoogle Scholar
  284. 284.
    Curtin JA, Simpson A, Belgrave D, Semic-Jusufagic A, Custovic A, Martinez FD. Methylation of IL-2 promoter at birth alters the risk of asthma exacerbations during childhood. Clin Exp Allergy. 2013;43(3):304–11. doi:10.1111/cea.12046.PubMedGoogle Scholar
  285. 285.
    Naumova AK, Al Tuwaijri A, Morin A, et al. Sex- and age-dependent DNA methylation at the 17q12-q21 locus associated with childhood asthma. Hum Genet. 2013;132(7):811–22. doi:10.1007/s00439-013-1298-z.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Liesbeth Duijts
    • 1
    • 2
    • 3
  • Irwin K. Reiss
    • 2
  • Guy Brusselle
    • 3
    • 4
    • 5
  • Johan C. de Jongste
    • 1
  1. 1.Division of Respiratory Medicine (Sp-3435), Department of PediatricsErasmus Medical CenterRotterdamThe Netherlands
  2. 2.Division of Neonatology, Department of PediatricsErasmus Medical CenterRotterdamThe Netherlands
  3. 3.Department of EpidemiologyErasmus Medical CenterRotterdamThe Netherlands
  4. 4.Department of Respiratory MedicineErasmus Medical CenterRotterdamThe Netherlands
  5. 5.Department of Respiratory MedicineGhent University HospitalGhentBelgium

Personalised recommendations